dc.creatorMartins-de-Souza, Daniel
dc.creatorFarias, Alessandro S
dc.date2015-Oct
dc.date2016-05-23T19:41:11Z
dc.date2016-05-23T19:41:11Z
dc.date.accessioned2018-03-29T01:28:41Z
dc.date.available2018-03-29T01:28:41Z
dc.identifierProteomics. v. 15, n. 19, p. 3281-3282, 2015-Oct.
dc.identifier1615-9861
dc.identifier10.1002/pmic.201500332
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/?term=26314682
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/235476
dc.identifier26314682
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1303719
dc.descriptionMultiple sclerosis is an idiopathic demyelinating disease of the CNS. Despite being extensively studied during the last decades, many molecular aspects of the disease are still to be elucidated. Moreover, biomarkers for treatment and early diagnosis are major issues to be tackled. In this edition of Kroksveen et al. (Proteomics 2015, 15, 3361-3369) present biomarker candidates for the early detection of multiple sclerosis. Despite the need for validation in larger sets of samples, this dataset contributes to resolve open questions associated to multiple sclerosis.
dc.description15
dc.description3281-3282
dc.languageeng
dc.relationProteomics
dc.relationProteomics
dc.rightsfechado
dc.sourcePubMed
dc.subjectBiomarkers
dc.subjectCerebrospinal Fluid
dc.subjectMultiple Sclerosis
dc.subjectQuantitative Ms
dc.subjectSecretogranin-1
dc.titleDeciphering The Biochemistry And Identifying Biomarkers To Multiple Sclerosis.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución